MedTrace Logo

Sleep-disordered Breathing in Infants With Myelomeningocele

NCT04251806 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2026-03-30

No results posted yet for this study

Summary

This study aims to determine whether the risk for sleep-disordered breathing in infants with myelomeningocele (a severe form of spina bifida) differs among those who underwent fetal vs. postnatal surgery, and to examine the link between sleep-disordered breathing and neurodevelopment.

Conditions

  • Sleep-disordered Breathing
  • Myelomeningocele

Interventions

DIAGNOSTIC_TEST

neonatal polysomnography

This procedure will allow the detection of sleep-disordered breathing in the neonatal period.

DIAGNOSTIC_TEST

2-year Bayley Exam

This procedure will evaluate neurodevelopmental outcomes.

DIAGNOSTIC_TEST

2-year polysomnography

This procedure will allow the detection of sleep-disordered breathing at 2 years of age.

Sponsors & Collaborators

Principal Investigators

  • John Barks, MD · University of Michigan

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-21
Primary Completion
2024-04-25
Completion
2026-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04251806 on ClinicalTrials.gov